544 Rectal Indomethacin Significantly Decreases the Rate of Moderate to Severe Post-ERCP Pancreatitis and Death and Should Be Given Before the Procedure: A Personalized Medicine Approach Using Meta-Analysis of Aggregate Subgroup Data From Randomized-Controlled Trials

Mohammad Yaghoobi,Mohammed A Alzahrani,Julia Mcnabb-Baltar,Myriam Martel,Alan N Barkun

doi:10.1016/j.gie.2017.03.107

544 Rectal Indomethacin Significantly Decreases the Rate of Moderate to Severe Post-ERCP Pancreatitis and Death and Should Be Given Before the Procedure: A Personalized Medicine Approach Using Meta-Analysis of Aggregate Subgroup Data From Randomized-Controlled Trials

Mohammad Yaghoobi, Mohammed A Alzahrani + Show 3 more

https://doi.org/10.1016/j.gie.2017.03.107

Copy DOI

Journal: Gastrointestinal endoscopy

Publication Date: Apr 28, 2017

Affiliation: Cochrane, McMaster University, Brigham and Women's Hospital, McGill University Health Centre

#Personalized Medicine Approach #Randomized-controlled Trials + Show 5 more

Abstract
Full-Text PDF
Similar Papers

Abstract

544 Rectal Indomethacin Significantly Decreases the Rate of Moderate to Severe Post-ERCP Pancreatitis and Death and Should Be Given Before the Procedure: A Personalized Medicine Approach Using Meta-Analysis of Aggregate Subgroup Data From Randomized-Controlled Trials

Full Text